(Q78427670)

English

TMC-2A, -2B and -2C, Novel Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374. I.Taxonomy of Producing Strains, Fermentation, and Biochemical Properties.

scientific article published on 01 March 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

TMC-2A, -2B and -2C, Novel Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374. I.Taxonomy of Producing Strains, Fermentation, and Biochemical Properties. (English)

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

Aspergillus flavus

1 reference

Aspergillus oryzae

1 reference

1 reference

1 reference

(2S,4R)-2-[[(3S)-2-[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]-6,8-dihydroxy-7-methoxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-hydroxy-4-methylpentanoic acid

1 reference

(2S,4S)-2-[[(3S)-2-[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]-6,8-dihydroxy-7-methoxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-hydroxy-4-methylpentanoic acid

1 reference

(2S)-2-[[(3S)-2-[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]-6,8-dihydroxy-7-methoxy-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-hydroxy-4-(hydroxymethyl)pentanoic acid

1 reference

author name string

NOBUAKI NONAKA

1

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

YASUYUKI ASAI

2

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

MAKI NISHIO

3

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

KOHEI TAKAHASHI

4

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

TORU OKUDA

5

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

SUMIKO TANAKA

6

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

TAKAHISA SUGITA

7

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

TETSUO OHNUKI

8

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

SABURO KOMATSUBARA

9

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

publication date

1997

3 references

16 September 2022

16 September 2022

number of pages

7

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/50/8/50_8_646/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.646?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

50

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

8

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

646-652

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.646?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

A simple estimation of cathepsin C using a new chromogenic substrate

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Dipeptidyl peptidase IV, a kidney brush-border serine peptidase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Preparative Purification of Dipeptidyl Peptidase IV

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.422

Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Direct association of adenosine deaminase with a T cell activation antigen, CD26

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.646

Identifiers

10.7164/ANTIBIOTICS.50.646

1 reference

10.7164/ANTIBIOTICS.50.646

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.646

14 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78427670&oldid=2127542356"